NFE2L2 and Lung Non-Small Cell Carcinoma: Association Evidence

Gene-Disorder Association · Article

Gene

NFE2L2

NFE2 Like BZIP Transcription Factor 2

Disorder

First reported 2007

Supporting publications 4

Key publication · gene–disorder Elevated peroxiredoxin 1, but not NF-E2-related factor 2, is an independent prognostic factor for disease recurrence and reduced survival in stage I non-small cell lung cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2007

Key publication · disorder cis-Dichlorodiammineplatinum(II), adriamycin, cyclophosphamide, CCNU, and vincristine in non-small cell lung carcinoma: a preliminary report.Cancer treatment reports · 1979

Manually curated

Association Review

In brief

The association between NFE2L2 (NFE2 Like BZIP Transcription Factor 2) and Lung Non-Small Cell Carcinoma is reported, with clinical genetic testing available.

Sources 1

Clinical variants 0

Symptoms 0

Compounds 0

Trials 0

Publications 4

At a glance

Association overview

A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.

Request access

Provenance

Evidence and sources

1 source

Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.

Request access

NFE2L2

The gene

1 source summary

A gene summary alongside the source descriptions it was distilled from.

Request access

Lung Non-Small Cell Carcinoma

The disorder

6 database identifiers

The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).

Request access

Literature

Reading

4 publications

Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.

Request access

Provenance

References & sources

6 references

Every source and publication cited across this dossier, as one numbered reference list.

Request access